Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2015, Article ID 201571, 10 pages
http://dx.doi.org/10.1155/2015/201571
Research Article

CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E2

Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada J1K 2R1

Received 22 August 2015; Revised 5 November 2015; Accepted 8 November 2015

Academic Editor: G. Rogler

Copyright © 2015 Bérengère Tanné et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Gunn, K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams, “A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 258–263, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Luther, H. L. Tang, P. L. Hyman, A. G. Farr, and J. G. Cyster, “Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 23, pp. 12694–12699, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. V. N. Ngo, H. L. Tang, and J. G. Cyster, “Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells,” The Journal of Experimental Medicine, vol. 188, no. 1, pp. 181–191, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. J. V. Stein, A. Rot, Y. Luo et al., “The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules,” The Journal of Experimental Medicine, vol. 191, pp. 61–76, 2000. View at Google Scholar
  5. H. Saeki, A. M. Moore, M. J. Brown, and S. T. Hwang, “Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes,” Journal of Immunology, vol. 162, no. 5, pp. 2472–2475, 1999. View at Google Scholar · View at Scopus
  6. R. A. Warnock, J. J. Campbell, M. E. Dorf, A. Matsuzawa, L. M. McEvoy, and E. C. Butcher, “The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules,” The Journal of Experimental Medicine, vol. 191, no. 1, pp. 77–88, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. S. C. Côté, S. Pasvanis, S. Bounou, and N. Dumais, “CCR7-specific migration to CCL19 and CCL21 is induced by PGE2 stimulation in human monocytes: involvement of EP2/EP4 receptors activation,” Molecular Immunology, vol. 46, no. 13, pp. 2682–2693, 2009. View at Publisher · View at Google Scholar
  8. R. Förster, A. Schubel, D. Breitfeld et al., “CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs,” Cell, vol. 99, no. 1, pp. 23–33, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. D. Gunn, S. Kyuwa, C. Tam et al., “Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization,” The Journal of Experimental Medicine, vol. 189, no. 3, pp. 451–460, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Goodwin and D. R. Webb, “Regulation of the immune response by prostaglandins,” Clinical Immunology and Immunopathology, vol. 15, no. 1, pp. 106–122, 1980. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Rocca and G. A. FitzGerald, “Cyclooxygenases and prostaglandins: shaping up the immune response,” International Immunopharmacology, vol. 2, no. 5, pp. 603–630, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Scandella, Y. Men, S. Gillessen, R. Förster, and M. Groettrup, “Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells,” Blood, vol. 100, no. 4, pp. 1354–1361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Luft, M. Jefford, P. Luetjens et al., “Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets,” Blood, vol. 100, no. 4, pp. 1362–1372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-A. Allaire and N. Dumais, “Involvement of the MAPK and RhoA/ROCK pathways in PGE2-mediated CCR7-dependent monocyte migration,” Immunology Letters, vol. 146, no. 1-2, pp. 70–73, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Traversari, S. Sozzani, K. R. Steffensen, and V. Russo, “LXR-dependent and -independent effects of oxysterols on immunity and tumor growth,” European Journal of Immunology, vol. 44, no. 7, pp. 1896–1903, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Y. Kalaany and D. J. Mangelsdorf, “LXRs and FXR: the yin and yang of cholesterol and fat metabolism,” Annual Review of Physiology, vol. 68, pp. 159–191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. M. Hanley, W. B. Puryear, S. Gummuluru, and G. A. Viglianti, “PPARγ and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection,” PLoS Pathogens, vol. 6, no. 7, Article ID e1000981, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. E. J. Villablanca, L. Raccosta, D. Zhou et al., “Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses,” Nature Medicine, vol. 16, no. 1, pp. 98–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Bruckner, D. Dickel, E. Singer, and D. F. Legler, “Converse regulation of CCR7-driven human dendritic cell migration by prostaglandin E2 and liver X receptor activation,” European Journal of Immunology, vol. 42, no. 11, pp. 2949–2958, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. G. Steube, D. D. Teepe, C. Meyer, M. Zaborski, and H. G. Drexler, “A model system in haematology and immunology: the human monocytic cell line MONO-MAC-1,” Leukemia Research, vol. 21, no. 4, pp. 327–335, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Bensinger and P. Tontonoz, “Integration of metabolism and inflammation by lipid-activated nuclear receptors,” Nature, vol. 454, no. 7203, pp. 470–477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Gerlo, P. Verdood, B. Gellersen, E. L. Hooghe-Peters, and R. Kooijman, “Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5′-monophosphate-mediated signaling pathways,” Journal of Immunology, vol. 173, no. 10, pp. 5952–5962, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Narumiya, Y. Sugimoto, and F. Ushikubi, “Prostanoid receptors: structures, properties, and functions,” Physiological Reviews, vol. 79, no. 4, pp. 1193–1226, 1999. View at Google Scholar · View at Scopus
  24. S. G. Harris, J. Padilla, L. Koumas, D. Ray, and R. P. Phipps, “Prostaglandins as modulators of immunity,” Trends in Immunology, vol. 23, no. 3, pp. 144–150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. F. Legler, P. Krause, E. Scandella, E. Singer, and M. Groettrup, “Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors,” The Journal of Immunology, vol. 176, no. 2, pp. 966–973, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Muthuswamy, J. Mueller-Berghaus, U. Haberkorn, T. A. Reinhart, D. Schadendorf, and P. Kalinski, “PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells,” Blood, vol. 116, no. 9, pp. 1454–1459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Vaughan and J. F. Oram, “ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL,” Journal of Lipid Research, vol. 47, no. 11, pp. 2433–2443, 2006. View at Publisher · View at Google Scholar · View at Scopus